News for Anika Therapeutics, Inc. (ANIK)

**media[560043]**

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Anika Therapeutics, Inc.

Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...

BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. ( ANIK), a global joint preservation company in early intervention orthopedics, ann

BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. ( ANIK), a global joint preservation company in early intervention orthopedics, tod

On December 31, 2024, Caligan Partners LP (Trades, Portfolio) made a strategic move by acquiring 15,856,653 shares of Verrica Pharmaceuticals Inc. This transact

On December 31, 2024, Dimensional Fund Advisors LP made a strategic decision to reduce its holdings in Anika Therapeutics Inc (ANIK) by 50,011 shares, marking a

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. ( ANIK), a global joint preservation company in early intervention orthopedics, tod

**media[499875]**

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. ( ANIK), a global joint preservation company in early intervention orthopedics, tod

Operator: Good morning, ladies and gentlemen, and welcome to Anika's Third Quarter Earnings Conference Call. [Operator Instructions].

Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsMatt Hall - Director, Corporate...

Anika (ANIK) delivered earnings and revenue surprises of -183.33% and 8.10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Anika Therapeutics Inc (ANIK) is set to release its Q3 2024 earnings on Oct 31, 2024. The consensus estimate for Q3 2024 revenue is $42.08 million, and the earn

Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031...

Global Hyaluronic Acid Market Size, Share & Trends Analysis Report By Grade (Cosmetic Grade, Food Grade, Pharmaceutical Grade), By Application (Aesthetics,...

Politan Provides Update on Why Masimo Shareholders Should Support Urgently Needed Board Change at Company's 2024 AGM

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Aesthetics Injectables...